|
Volumn 18, Issue 2, 2001, Pages 417-424
|
Immunomodulation by anticancer chemotherapy: more is not always better (review).
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
INTERLEUKIN DERIVATIVE;
PACLITAXEL;
ANIMAL;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MACROPHAGE;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
NATURAL KILLER CELL;
REVIEW;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
HUMANS;
IMMUNOTHERAPY;
INTERLEUKINS;
KILLER CELLS, NATURAL;
MACROPHAGES;
PACLITAXEL;
MLCS;
MLOWN;
|
EID: 0035256620
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.18.2.417 Document Type: Review |
Times cited : (39)
|
References (112)
|